mbgogl.blogg.se - Swish fayetteville

#Swish fayetteville trial

Topical or inhaled corticosteroids are allowed

Chronic treatment with corticosteroids or other immunosuppressive agents.

Known severely impaired lung function (spirometry and DLCO 50% or less of normal and O2 saturation 88% or less at rest on room air).

active (acute or chronic) or uncontrolled severe infection, liver disease such as cirrhosis, decompensated liver disease (except for Hep B and Hep C positive patients).

Symptomatic congestive heart failure of New York heart Association Class III or IV.

Unstable angina pectoris, symptomatic congestive heart failure, myocardial infarction ≤6 months prior to start of everolimus, serious uncontrolled cardiac arrhythmia, or any other clinically significant cardiac disease.

Patients who have any severe and/or uncontrolled medical conditions such as:

#Swish fayetteville trial

Patients with a known history of impaired fasting glucose or diabetes mellitus (DM) may be included, however blood glucose and antidiabetic treatment must be monitored closely throughout the trial and adjusted as necessary

Age ≥ 55 years and one year or more of amenorrhea.

Postmenopausal status is defined either by:

Histological or cytological confirmation of hormone-receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer.

Adult women > 18 years of age with metastatic or locally advanced breast cancer not amenable to curative treatment by surgery or radiotherapy.Why Should I Register and Submit Results?.